Godavari Drugs
add_icon

Godavari Drugs

82.51
-2.87
(-3.36%)
Market Cap
62.14 Cr
PE Ratio
14.67
Volume
4,821.00
Day High - Low
87.69 - 82.40
52W High-Low
115.00 - 69.70
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
62.14 Cr
EPS
5.82
PE Ratio
14.67
PB Ratio
1.48
Book Value
57.56
EBITDA
12.80
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
10.10
Debt to Equity
1.48
Forecast For
Actual

Company News

View All News
Caret
positive
Godavari Drugs Limited successfully concluded its 1st EGM for FY 2025-26 on February 12, 2026, with shareholders approving two special resolutions for preferential equity shares and convertible warrants issuance.
neutral
Godavari Drugs reported Q3FY26 net profit of ₹75.76 lakhs with revenue of ₹2218.43 lakhs. Board approved ₹5.50 crore working capital loan from ICICI Bank for new order execution.
positive
Godavari Drugs Limited board approves preferential issue of 23.60 lakh convertible warrants and 25.97 lakh equity shares at ₹89 each to promoters and non-promoters, subject to shareholder approval in EGM scheduled for February 12, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,724.40
#1 4,13,741.32
37.53
#1 54,729.00
9.71
#1 10,980
16.07
58.16
6,291.00
1,67,006.28
67.40
9,712.00
18.67
2,191
-1.02
53.89
4,241.70
1,43,558.40
62.90
11,539.40
6.99
1,911
26.24
66.58
1,341.10
1,08,330.28
23.68
28,409.50
7.12
5,291
-57.18
43.41
1,280.40
1,06,866.07
19.34
33,741.20
16.73
5,725
-15.28
60.10
2,219.40
1,01,381.93
21.81
22,909.50
13.74
3,306
#1 37.44
57.52
900.75
90,636.53
#1 18.06
23,511.00
18.55
4,615
-0.32
49.52
2,024.30
83,564.13
46.65
12,744.20
#1 20.90
2,007
7.65
38.95
1,158.80
67,303.29
19.60
32,345.60
9.43
3,484
7.59
47.48
5,392.00
64,469.45
26.53
13,458.30
3.70
2,216
1.90
37.57
Growth Rate
Revenue Growth
-27.34 %
Net Income Growth
-20.00 %
Cash Flow Change
-39.16 %
ROE
-29.07 %
ROCE
-34.05 %
EBITDA Margin (Avg.)
26.55 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
55
71
76
65
84
96
123
161
160
157
114
99
Expenses
49
67
70
60
78
90
113
150
150
143
102
88
EBITDA
6
5
6
5
6
6
10
12
11
14
13
12
Operating Profit %
11 %
6 %
7 %
6 %
7 %
6 %
8 %
7 %
6 %
8 %
10 %
11 %
Depreciation
1
1
1
1
1
1
1
2
2
2
2
3
Interest
1
2
3
2
3
3
3
3
4
5
5
4
Profit Before Tax
5
2
3
1
2
2
6
7
5
7
6
5
Tax
1
1
1
1
1
0
2
2
1
1
1
1
Net Profit
4
1
2
1
1
2
4
5
4
6
4
4
EPS in ₹
4.84
1.79
2.40
1.10
1.60
2.66
5.48
6.97
5.03
7.37
5.82
4.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
35
51
56
63
74
84
91
101
121
135
143
Fixed Assets
7
9
13
15
15
14
22
26
25
27
33
Current Assets
27
40
43
47
57
61
68
74
87
89
79
Capital Work in Progress
0
1
0
1
2
9
1
1
9
18
30
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
27
41
43
48
57
61
68
75
87
90
81
Total Liabilities
35
51
56
63
74
84
91
101
121
135
143
Current Liabilities
17
31
34
37
46
51
51
58
74
82
73
Non Current Liabilities
5
5
6
9
9
12
16
14
14
14
27
Total Equity
13
14
16
17
18
20
24
30
33
39
43
Reserve & Surplus
6
7
9
10
11
13
17
22
26
31
36
Share Capital
8
8
8
8
8
8
8
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
1
-0
-0
0
1
1
-1
-0
Investing Activities
-0
-2
-3
-3
-2
-7
-1
-5
-9
-13
-20
Operating Activities
-6
-5
5
4
4
6
1
11
13
18
11
Financing Activities
6
7
-2
-0
-2
0
0
-6
-4
-6
8

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
55.86 %
56.13 %
56.13 %
56.13 %
56.36 %
56.92 %
56.92 %
53.12 %
53.12 %
53.16 %
53.16 %
53.16 %
53.16 %
53.16 %
52.63 %
52.63 %
52.63 %
52.63 %
52.61 %
52.61 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
36.16 %
36.05 %
36.33 %
36.14 %
35.59 %
35.87 %
35.90 %
39.27 %
7.27 %
38.75 %
38.99 %
38.87 %
39.10 %
38.96 %
39.76 %
39.98 %
39.93 %
37.09 %
37.05 %
36.88 %
Others
7.49 %
7.32 %
7.05 %
7.23 %
7.56 %
6.71 %
6.68 %
7.12 %
39.11 %
7.59 %
7.35 %
7.47 %
7.24 %
7.38 %
7.11 %
6.89 %
6.95 %
9.78 %
9.84 %
10.01 %
No of Share Holders
0
4,136
4,567
5,394
5,750
6,034
6,232
5,968
6,555
6,561
7,019
6,894
7,005
7,044
7,709
7,915
7,881
7,828
7,720
7,483

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2024 91.80 139.65
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 122.50 117.20
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 102.90 101.35
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 98.48 97.99
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 82.85 86.51
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 82.57 86.51
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 83.61 84.00
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 93.16 89.37
12 Feb 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Feb 2026 85.81 89.68

Announcements

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report10 days ago
Shareholder Meeting / Postal Ballot-Outcome of EGM10 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025Feb 11, 2026
Board Meeting Outcome for Outcome Of Board Meeting And Disclosures Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 11, 2026
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ending On December 31 2025.Feb 07, 2026
CORRIGENDUM IN CONTINUATION TO THE NOTICE AND EXPLANATORY STATEMENT ATTACHED THERETO DATED 15.01.2026 CONVENING THE 01St EXTRA ORDINARY GENERAL MEETING FOR FY 2025-26 OF GODAVARI DRUGS LIMITED TO BE HELD ON THURSDAY 12.02.2026 AT 11:00 A.M.Feb 02, 2026
EXTRA-ORDINARY GENERAL MEETING WILL BE HELD ON THURSDAY THE 12TH DAY OF FEBRUARY 2026 AT 11:00 A.M. THROUGH VIDEO CONFERENCING AND OTHER AUDIO-VISUAL MEANSJan 21, 2026
Announcement under Regulation 30 (LODR)-Preferential IssueJan 15, 2026
Board Meeting Outcome for Meeting Held On 15.01.2026Jan 15, 2026
Board Meeting Intimation for Options Of Consideration Of Fund-Raising ProposalJan 12, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
Clarification On Price Movement In The Equity Shares Of Godavari Drugs Limited Ref: L/SURV/ONL/PV/AJ/ 2025-2026 / 3277Jan 08, 2026
Clarification sought from Godavari Drugs LtdJan 08, 2026
Closure of Trading WindowDec 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 17, 2025
Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations 2015 For The Quarter And Half Year Ended 30Th September 2025Nov 14, 2025
Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025Nov 14, 2025
Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Friday November 14 2025.Nov 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Scrutinizers ReportSep 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 29, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2025
Closure of Trading WindowSep 19, 2025
Dispatch Of Letter To ShareholdersSep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Notice Of 37Th Annual General Meeting Of The CompanySep 03, 2025
Reg. 34 (1) Annual Report.Sep 03, 2025
Intimation Of Book Closure For The Purpose Of 37Th Annual General MeetingSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Shareholder Meeting / Postal Ballot - 37Th Annual General Meeting Scheduled On 27Th September 2025Aug 13, 2025
Un-Audited Financial Results For The Period Ended 30.06.2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2025Aug 13, 2025
Rescheduling Of 37Th Annual General Meeting (AGM) Of The CompanyAug 01, 2025
Board Meeting Intimation for Unaudited Standalone Financial Results Of The Company For The First Quarter Ended 30Th June 2025 And Rescheduling Of 37Th Annual General Meeting (AGM) Of The CompanyAug 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
INTIMATION FOR RE-CONSTITUTION OF COMMITTEES OF THE BOARDMay 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2025
AUDITED STANDALONE FINANCIALS OF THE COMPANY FOR THE QUARTER AND YEAR ENDED ON 31-03-2025May 29, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited Held On Thursday 29Th May 2025 Ref: Reg. 30 Read With Reg. 33 Of SEBI (LODR) Regulations 2015 May 29, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Board Meeting Intimation for Approval Of The Audited Financial Results Of The Company Along With Audit Report For The Quarter And Year Ended On 31.03.2025 And Induction Of New Director On The Board Of The CompanyMay 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Integrated Filing (Financial)Feb 12, 2025

Technical Indicators

RSI(14)
Neutral
43.76
ATR(14)
Less Volatile
5.36
STOCH(9,6)
Oversold
16.22
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.94
ADX(14)
Strong Trend
31.61
UO(9)
Bearish
34.10
ROC(12)
Downtrend And Accelerating
-7.62
WillR(14)
Oversold
-90.52